Abstract
Serotonin has been implicated in the pathogenesis of hypertension because of its ability to induce vasoconstriction via stimulation of serotonin 2 (5-HT2) receptors. Recently, an association between the T102C functional polymorphism of the serotonin 2A (5-HT2A) receptor gene and hypertension in the UK has been reported. Another association study, however, failed to replicate this association in a Chinese population. We therefore investigated the possible association between the 5-HT2A T102C polymorphism and hypertension in two large Japanese populations (n=2,968 total). We also investigated the possible interaction between the 5-HT2A T102C polymorphism and the G/T (Lys198Asn) polymorphism of the endothelin-1 (ET-1) gene, based on robust biological evidence for the existence of an interaction between the serotonin and endothelin systems. The results showed that there was no significant difference in the frequencies of the alleles and genotypes between the hypertensive and normotensive subjects. However, a significant interaction between the 5-HT2A T102C and ET-1 G/T polymorphisms in their association with hypertension (p=0.0040) and with diastolic blood pressure (p=0.0013) was revealed. A marginally significant interaction in the association with systolic blood pressure was also shown (p=0.045). The associations of the 5-HT2A T102C polymorphism with hypertension and diastolic blood pressure in ET-1 T allele carriers were significant (p=0.0056 and 0.021, respectively). The association of the 5-HT2A T102C polymorphism with systolic blood pressure in ET-1 T allele carriers was marginally significant (p=0.054). Thus, the present study suggests that the 5-HT2A T102C and ET-1 G/T polymorphisms are interactively associated with hypertension.
Similar content being viewed by others
Article PDF
References
Frishman WH, Grewall P : Serotonin and the heart. Ann Med 2000; 32: 195–209.
Watts SW : Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate–salt hypertension. Hypertension 2002; 39: 825–829.
Liolitsa D, Powell JF, Prince M, Lovestone S : Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertension. J Hum Hypertens 2001; 15: 335–339.
Yu BN, Wang A, Zhou G, et al: T102C genetic polymorphism of the 5-HT2A receptor in Chinese hypertensive patients and healthy controls. Clin Exp Pharmacol Physiol 2004; 31: 847–849.
Abe M, Wu Z, Yamamoto M, et al: Association of dopamine beta-hydroxylase polymorphism with hypertension through interaction with fasting plasma glucose in Japanese. Hypertens Res 2005; 28: 215–221.
Yang ZH, Richard V, von Segesser L, et al: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990; 82: 188–195.
Haugen G, Stray-Pedersen S : Effects of endothelin-1 on vascular tension in human umbilical vessels. Early Hum Dev 1991; 27: 25–32.
Pietraszek MH, Takada Y, Takada A : Endothelins inhibit serotonin-induced platelet aggregation via a mechanism involving protein kinase C. Eur J Pharmacol 1992; 219: 289–293.
Balligand JL, Godfraind T : Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins. J Cardiovasc Pharmacol 1994; 24: 618–625.
Okatani Y, Taniguchi K, Sagara Y : Amplifying effect of endothelin-1 on serotonin-induced vasoconstriction of human umbilical artery. Am J Obstet Gynecol 1995; 172: 1240–1245.
Yoshida M, Aizawa H, Hara N : Effect of endothelin-1 on the serotonin-induced contraction of smooth muscle in the guinea pig trachea. Respiration 1999; 66: 59–64.
Liras A, Catalan RE, Martinez AM : Synergistic effect of endothelin-1 and serotonin in rabbit platelets: effect on tyrosine phosphorylation. Thromb Res 2000; 100: 325–331.
Watanabe T, Pakala R, Katagiri T, Benedict CR : Angiotensin II and serotonin potentiate endothelin-1−induced vascular smooth muscle cell proliferation. J Hypertens 2001; 19: 731–739.
Watanabe T, Pakala R, Katagiri T, Benedict CR : Antioxidant N-acetylcysteine inhibits vasoactive agents–potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells. Hypertens Res 2002; 25: 311–315.
Yao L, Kobori H, Rahman M, et al: Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004; 27: 493–500.
Tanaka C, Kamide K, Takiuchi S, Kawano Y, Miyata T : Evaluation of the Lys198Asn and −134delA genetic polymorphisms of the endothelin-1 gene. Hypertens Res 2004; 27: 367–371.
Jin JJ, Nakura J, Wu Z, et al: Association of endothelin-1 gene variant with hypertension. Hypertension 2003; 41: 163–167.
Holloway JW, Beghe B, Turner S, Hinks LJ, Day IN, Howell WM : Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). Hum Mutat 1999; 14: 340–347.
Ishikawa K, Baba S, Katsuya T, et al: T+31C polymorphism of angiotensinogen gene and essential hypertension. Hypertension 2001; 37: 281–285.
Nordfors L, Jansson M, Sandberg G, et al: Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′ nuclease (Taqman®) assay. Hum Mutat 2002; 19: 395–401.
de Kok JB, Wiegerinck ET, Giesendorf BA, Swinkels DW : Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat 2002; 19: 554–559.
Ioannidis JP, Ntzani EE, Trikalinos TA : ‘Racial’ differences in genetic effects for complex diseases. Nat Genet 2004; 36: 1312–1318.
Peroutka SJ : Serotonin receptor variants in disease: new therapeutic opportunities? Ann N Y Acad Sci 1998; 861: 16–25.
Polesskaya OO, Sokolov BP : Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002; 67: 812–822.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamamoto, M., Jin, J., Wu, Z. et al. Interaction between Serotonin 2A Receptor and Endothelin-1 Variants in Association with Hypertension in Japanese. Hypertens Res 29, 227–232 (2006). https://doi.org/10.1291/hypres.29.227
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.227
Keywords
This article is cited by
-
Association between serotonin 2A receptor (HTR2A) genetic variations and risk of hypertension in a community-based cohort study
BMC Medical Genetics (2020)
-
Serotonin risk factors for the development of hypertension in pregnancy
Archives of Gynecology and Obstetrics (2015)
